AgileMD acquired by Wolters Kluwer

Wolters Kluwer Health agreed on 13 November 2026 to acquire AgileMD for $20–50M, plus an additional $40M payable upon completion of the transaction and contingent upon the achievement of performance targets. Completion is expected during the first quarter of 2027 or earlier, subject to regulatory approvals, and the 23 employees join the acquirer with co-founders Borna Safabakhsh and Dana Edelson. Founded in 2011 at San Francisco, AgileMD supplies clinical decision support embedded within hospital electronic record systems. Its pathways translate a hospital’s own protocols into the sequence a clinician follows at the bedside, while its eCART system monitors patient data continuously and signals deterioration, having been cleared by the Food and Drug Administration. It serves more than 400 hospitals and over 150,000 clinical users, with more than 4,800 pathways in operation, and expects recurring revenue of $5–25M by the end of 2026. The acquisition addresses the gap between reference material and clinical action. The acquirer’s existing product tells a physician what the evidence indicates, consulted as a reference, whereas the acquired system places that guidance inside the sequence of orders and documentation the physician is already executing, which is where it changes what is done rather than what is known. Local protocol determines much of hospital practice, each institution adapting published guidance to its own staffing, equipment and patient population, and a system operationalising those local variants reaches a layer that a universally published reference cannot. The acquirer expects the transaction to return at or above its after-tax weighted average cost of capital of 8% within three to five years, with an immaterial effect on adjusted earnings.